Cargando…

Desferioximine induced Ototoxicity in Thalassemic patients

BACKGROUND: Thalassemia is a hereditary disorder requiring regular blood transfusion. PURPOSE: To determine hearing sensitivity in transfusion-dependent thalassemics who were receiving desferioximine and on oral iron chelation (desferioximine) therapy. METHODS: 26 patients with B-thelassemia in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vir, Dharam, Panda, N. K., Marwaha, R. K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Indian Academy of Neurosciences 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117009/ https://www.ncbi.nlm.nih.gov/pubmed/25205902 http://dx.doi.org/10.5214/ans.0972.7531.1017407

Ejemplares similares

Direct antiglobulin test positivity in multi-transfused thalassemics
por: Jain, Ashish, et al.
Publicado: (2016)

Enhanced quinone-induced oxidative stress in erythrocytes of thalassemic patients
por: Alfanas'ev, I.I., et al.
Publicado: (1995)

Outcome of iron reduction therapy in ex-thalassemics
por: Aboobacker, Fouzia N., et al.
Publicado: (2021)

Iron Overload in Transfusion-Dependent Indonesian Thalassemic Patients
por: Fianza, Pandji Irani, et al.
Publicado: (2021)

The Antioxidant Effect of Erythropoietin on Thalassemic Blood Cells
por: Amer, Johnny, et al.
Publicado: (2010)

The relevance of ototoxicity induced by radiotherapy
por: Huang, Yan, et al.
Publicado: (2023)

High phosphate intake induces bone loss in nephrectomized thalassemic mice
por: Wanna-udom, Sasithorn, et al.
Publicado: (2022)

Iron deposits in the knee joints of a thalassemic patient
por: Economides, Charalambos P, et al.
Publicado: (2012)

Transcatheter Aortic Valve Replacement (TAVR) in Thalassemic Patients
por: Mehta, Yatin, et al.
Publicado: (2022)

P1586: COMPARISON OF FREQUENCY OF TRANSFUSION RELATED COMPLICATIONS IN THALASSEMIC AND NON-THALASSEMIC PATIENTS RECEIVING NON LEUKODEPLETED RED CELL CONCENTRATE.
por: Imran, Tanzeel, et al.
Publicado: (2023)

Ototoxicity
por: Fechter, Laurence D., et al.
Publicado: (2005)

Compressive Dorsal Myelopathy Secondary to Extramedullary Hematopoiesis in a Thalassemic Patient
por: Ismail, Ismail Ibrahim, et al.
Publicado: (2019)

Mesiodistal crown diameters and tooth size discrepancy of permanent dentition in thalassemic patients
por: Hattab, Faiez N.
Publicado: (2013)

Factors regulating Hb F synthesis in thalassemic diseases
por: Mastropietro, Fabrizio, et al.
Publicado: (2002)

Neurological manifestations in speech after snake bite: a rare case
por: Vir, Dharam, et al.
Publicado: (2010)

Atrial and ventricular function in thalassemic patients with supra-ventricular arrhythmias
por: Monte, Ines, et al.
Publicado: (2009)

The Reproductive Behavior of Families with Thalassemic Children in Hormozgan
por: Safari Moradabadi, Ali, et al.
Publicado: (2015)

Perception of Parents of Thalassemic Child to Thalassemia in Pakistan
por: Saleem, Noman, et al.
Publicado: (2021)

Arsenic ototoxicity
por: Kesici, Gülin Gökçen
Publicado: (2016)

Study of behavioral problems in multi-transfused thalassemic children
por: Hongally, Chandrashekar, et al.
Publicado: (2012)

Growth pattern in thalassemic children and their correlation with serum ferritin
por: Rathaur, Vyas Kumar, et al.
Publicado: (2020)

Salvianolic acid B inhibits ototoxic drug–induced ototoxicity by suppression of the mitochondrial apoptosis pathway
por: Zheng, Zhiwei, et al.
Publicado: (2020)

The Effect of Dexpanthenol on Ototoxicity Induced by Cisplatin
por: Toplu, Yuksel, et al.
Publicado: (2016)

Mitophagy Impairment Aggravates Cisplatin-Induced Ototoxicity
por: Cho, Sung Il, et al.
Publicado: (2021)

Mechanisms of Aminoglycoside- and Cisplatin-Induced Ototoxicity
por: Steyger, Peter S.
Publicado: (2021)

Ototoxicity of cisplatinum.
por: Brock, P., et al.
Publicado: (1991)

Is Cyclosporine Ototoxic?
por: Waissbluth, Sofia
Publicado: (2020)

Mitophagy in ototoxicity
por: Han, Hezhou, et al.
Publicado: (2023)

The role of P-wave dispersion in dystrophic and thalassemic cardiomyopathy
por: Russo, Vincenzo, et al.
Publicado: (2017)

Thalassemic Child Presenting with Anosmia due to COVID-19
por: Marhaeni, Wulandewi, et al.
Publicado: (2020)

Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection
por: Sheth, Sandeep, et al.
Publicado: (2017)

The Effects of Riluzole on Cisplatin-induced Ototoxicity
por: Üstün Bezgin, Selin, et al.
Publicado: (2019)

Mechanism and Prevention of Ototoxicity Induced by Aminoglycosides
por: Fu, Xiaolong, et al.
Publicado: (2021)

Ototoxicity of cisplatinum in children and adolescents.
por: Skinner, R., et al.
Publicado: (1990)

Secondary Hemochromatosis Leading to Acute Coronary Syndrome in a Thalassemic Patient
por: Ullah, Hidayat, et al.
Publicado: (2023)

Nephrectomy Does not Exacerbate Cancellous Bone loss in Thalassemic Mice
por: Lotinun, Sutada, et al.
Publicado: (2020)

Local Anesthesia Onset and Pain Perception in Hemophilic and Thalassemic Conditions
por: Das, Supriya, et al.
Publicado: (2023)

Thalassemic DNA-Containing Red Blood Cells Are under Oxidative Stress
por: Dana, Mutaz, et al.
Publicado: (2012)

Reticulocyte hemoglobin equivalent to detect thalassemia and thalassemic hemoglobin variants
por: Sudmann, Å A, et al.
Publicado: (2012)

Calpain mediated cisplatin-induced ototoxicity in mice
por: Chang, Liang, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8csthuftgg8lia9i9b7ddjt7gk